Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.)

[1]  C. Bassi,et al.  Early graft injuries after pancreatic transplantation in syngeneic rats. Cytoprotective effects of gabexate-mesilate. , 1991, International journal of pancreatology : official journal of the International Association of Pancreatology.

[2]  C. Bassi,et al.  Continuous peritoneal dialysis in acute experimental pancreatitis in dogs , 1989, International journal of pancreatology : official journal of the International Association of Pancreatology.

[3]  I. Renner,et al.  The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat , 1989, International journal of pancreatology : official journal of the International Association of Pancreatology.

[4]  M. Otsuki,et al.  The Protective Effect of the Trypsin Inhibitor Urinastatin on Cerulein‐Induced Acute Pancreatitis in Rats , 1988, Pancreas.

[5]  W. Steinberg,et al.  Treatment of acute pancreatitis: Comparison of animal and human studies , 1987 .

[6]  L. Ferrell,et al.  Gabexate Mesilate (FOY) Protects Against Ceruletide‐Induced Acute Pancreatitis in the Rat , 1987, Pancreas.

[7]  A. Megibow,et al.  Acute pancreatitis: prognostic value of CT. , 1985, Radiology.

[8]  F. Schmidt,et al.  Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. , 1985, Clinical biochemistry.

[9]  N. Back.  DEATH FROM ACUTE PANCREATITIS , 1978, The Lancet.

[10]  J. C. Ferguson,et al.  A single‐centre double‐blind trial of Trasylol therapy in primary acute pancreatitis , 1978, The British journal of surgery.

[11]  Y. Tamura,et al.  Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase. , 1977, Biochimica et biophysica acta.

[12]  C. Rigby,et al.  A controlled trial of Trasylol in the treatment of acute pancreatitis , 1974, The British journal of surgery.

[13]  M. Pérez-Mateo,et al.  Multicenter double-blind trial of gabexate mesylate (FOY) in unselected patients with acute pancreatitis. , 1992, Digestion.

[14]  B. Göke,et al.  Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models. , 1989, Gastroenterology.

[15]  K. Schmid,et al.  Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine. , 1983, Enzyme.

[16]  C. Imrie,et al.  Effective aprotinin therapy in canine experimental bile-trypsin pancreatitis. , 1981, Digestion.

[17]  N. Tanaka,et al.  Comparative clinical study of FOY and Trasylol in acute pancreatitis. , 1979, Advances in experimental medicine and biology.

[18]  K. Ohlsson,et al.  Studies on the Influence of Trasylol on the Partition of Trypsin between the Human Plasma Protease Inhibitors in vitro , 1978, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.